Telix Pharmaceuticals Ltd (TLX) income statement
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
$8.37−0.34 (-3.90%)
Close on Nov 20, 2026Market cap $2.84BP/E –Yield –
Telix Pharmaceuticals Ltd financial ratios
See a number that looks wrong?